[go: up one dir, main page]

GB201712096D0 - Immunogenic conjugates and use thereof - Google Patents

Immunogenic conjugates and use thereof

Info

Publication number
GB201712096D0
GB201712096D0 GBGB1712096.5A GB201712096A GB201712096D0 GB 201712096 D0 GB201712096 D0 GB 201712096D0 GB 201712096 A GB201712096 A GB 201712096A GB 201712096 D0 GB201712096 D0 GB 201712096D0
Authority
GB
United Kingdom
Prior art keywords
immunogenic conjugates
immunogenic
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1712096.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB1712096.5A priority Critical patent/GB201712096D0/en
Publication of GB201712096D0 publication Critical patent/GB201712096D0/en
Priority to EP17816487.7A priority patent/EP3544625A2/en
Priority to PCT/EP2017/080145 priority patent/WO2018096007A2/en
Priority to BR112019010227A priority patent/BR112019010227A2/en
Priority to US16/462,624 priority patent/US12036285B2/en
Priority to CA3044569A priority patent/CA3044569A1/en
Priority to CN201780084552.7A priority patent/CN110214022A/en
Priority to JP2019527901A priority patent/JP7100031B2/en
Priority to BE2017/5855A priority patent/BE1025210B1/en
Priority to MX2019006104A priority patent/MX2019006104A/en
Priority to JP2022105784A priority patent/JP7439174B2/en
Ceased legal-status Critical Current

Links

GBGB1712096.5A 2016-11-25 2017-07-27 Immunogenic conjugates and use thereof Ceased GB201712096D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB1712096.5A GB201712096D0 (en) 2017-07-27 2017-07-27 Immunogenic conjugates and use thereof
MX2019006104A MX2019006104A (en) 2016-11-25 2017-11-23 Immunogenic conjugates and use thereof.
US16/462,624 US12036285B2 (en) 2016-11-25 2017-11-23 Immunogenic conjugates and use thereof
PCT/EP2017/080145 WO2018096007A2 (en) 2016-11-25 2017-11-23 Immunogenic conjugates and use thereof
BR112019010227A BR112019010227A2 (en) 2016-11-25 2017-11-23 immunogenic conjugate, process for preparing immunogenic conjugate, immunogenic composition, vaccine, and use of nomv
EP17816487.7A EP3544625A2 (en) 2016-11-25 2017-11-23 Immunogenic conjugates and use thereof
CA3044569A CA3044569A1 (en) 2016-11-25 2017-11-23 Immunogenic conjugates and use thereof
CN201780084552.7A CN110214022A (en) 2016-11-25 2017-11-23 Immunogenic conjugate and application thereof
JP2019527901A JP7100031B2 (en) 2016-11-25 2017-11-23 Immunogenic conjugates and their use
BE2017/5855A BE1025210B1 (en) 2016-11-25 2017-11-23 IMMUNOGENIC CONJUGATES AND THEIR USE
JP2022105784A JP7439174B2 (en) 2016-11-25 2022-06-30 Immunogenic conjugates and their uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1712096.5A GB201712096D0 (en) 2017-07-27 2017-07-27 Immunogenic conjugates and use thereof

Publications (1)

Publication Number Publication Date
GB201712096D0 true GB201712096D0 (en) 2017-09-13

Family

ID=59778865

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1712096.5A Ceased GB201712096D0 (en) 2016-11-25 2017-07-27 Immunogenic conjugates and use thereof

Country Status (1)

Country Link
GB (1) GB201712096D0 (en)

Similar Documents

Publication Publication Date Title
ZA202003833B (en) Conjugates and preparation and use thereof
IL258248A (en) Affinity-oligonucleotide conjugates and uses thereof
IL261493A (en) Napi2b-targeted antibody-drug conjugates and methods of use thereof
IL250711A0 (en) Conjugates comprising cell-binding agents and cytotoxic agents
IL265471A (en) Affinity-oligonucleotide conjugates and uses thereof
SI3592393T1 (en) Releasable conjugates
IL275208A (en) Hsp90-targeting conjugates and formulations thereof
IL248961A0 (en) Auristatin derivatives and conjugates thereof
PL3380124T3 (en) Conjugates comprising self-immolative groups and methods related thereto
IL275190A (en) Anti-cd22 antibody-maytansine conjugates, combinations, and methods of use thereof
ZA201707464B (en) Multi-ligand drug conjugates and uses thereof
IL277791A (en) Hsp90-targeting conjugates and formulations thereof
PT3271329T (en) Novel hydrophilic linkers and ligand-drug conjugates thereof
PT3544637T (en) Nomv-antigen conjugates and use thereof
IL251120A0 (en) Immunogenic/therapeutic glycoconjugate compositions and uses thereof
SG11202101517PA (en) Isoquinoline-steroid conjugates and uses thereof
IL258759A (en) Anti-cd3-folate conjugates and their uses
ZA201608327B (en) Curcumin-peptide conjugates and formulations thereof
GB201615725D0 (en) Novel cytotoxic agents and conjugates thereof
IL279855B2 (en) Improvements in immunogenic conjugates
EP3703745A4 (en) Immunogenic conjugates and methods of use thereof
GB201712096D0 (en) Immunogenic conjugates and use thereof
GB201911959D0 (en) Immunogenic compositions and uses therefor
GB201818562D0 (en) Pyrrolobenzodiazephones and conjugates thereof
GB201712101D0 (en) nOMV-ANTIGEN CONJUGATES AND USE THEREOF

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)